Development and Progression of Portal Hypertensive Gastropathy in Patients With Chronic Hepatitis C

@article{Fontana2011DevelopmentAP,
  title={Development and Progression of Portal Hypertensive Gastropathy in Patients With Chronic Hepatitis C},
  author={Robert J Fontana and Arun J Sanyal and Marc G Ghany and Herbert L. Bonkovsky and Timothy R. Morgan and Heather J. Litman and A. E. Reid and William M. Lee and Deepa Naishadham},
  journal={The American Journal of Gastroenterology},
  year={2011},
  volume={106},
  pages={884-893}
}
OBJECTIVES:The objective of this study was to determine the incidence and risk factors associated with new-onset and worsening portal hypertensive gastropathy (PHG) in patients with chronic hepatitis C (CHC).METHODS:A total of 831 CHC patients with bridging fibrosis or cirrhosis at the time of entry were prospectively monitored for clinical and histological liver disease progression while receiving either low-dose peginterferon α2a or no antiviral therapy in the HALT-C (Hepatitis C Antiviral… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Final results of the EPIC 3 Cirrhosis Maintenance Trial : pegintron maintenance therapy in cirrhotic ( METAVIR F 4 ) HCV patients , who failed to respond to interferon / ribavirin therapy

  • J Bruix, T Poynard, M Colombo
  • Gastroenterology
  • 2009

Paired biopsies illustrate racial diff erences in fi brosis progression in HCV patients ( abstract )

  • V Tencate, JE Layden-Almer, M Wolfert
  • 2009

Colchicine versus peginterferon alfa2b long term therapy: results of the 4 year CoPilot trial (abstract

  • R Levine, R Brown
  • J Hepatol
  • 2008